TickerGuard
Buy Day today: Neutral (52) Mixed market breadth · major macro event coming up
KRRO

Korro Bio, Inc.

Healthcare · Biotechnology

9.90$ +3.7% vs. previous close Closing price · As of: Sep 30, 2026

Statements

Balance Sheet

Korro Bio, Inc. (KRRO) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 163 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet KRRO
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
96 222 198 250 244 226 202 180 162 114 184 163
49 173 146 164 153 132 121 103 98 82 120 121
46 166 139 91 63 56 64 34 25 22 62 25
46 166 139 157 137 126 115 96 93 75 114 115
– 0.0 – – 10 1.7 1.9 1.1 0.8 1.0 0.0 0.0
40 52 47 52 64 66 63 65 63 62 64 60
9.5 19 11 12 14 15 13 17 15 12 15 13
1.0 2.0 1.2 0.5 – 1.3 2.3 2.4 3.1 2.7 2.8 2.9
2.8 7.3 4.7 5.7 6.0 4.0 4.2 5.2 2.3 1.7 2.0 3.6
56 170 151 198 180 160 139 115 99 51 120 103
-158 -183 -203 -224 -245 -267 -290 -316 -334 -384 -403 -422
5.7 8.0 8.0 9.0 9.3 8.9 9.4 9.4 9.4 9.4 12 18

Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?